Wolverine Trading’s Definium Therapeutics DFTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$1.82M Buy
151,200
+43,700
+41% +$408K ﹤0.01% 2263
2025
Q2
$704K Sell
107,500
-23,900
-18% -$157K ﹤0.01% 2636
2025
Q1
$813K Buy
131,400
+52,800
+67% +$378K ﹤0.01% 2446
2024
Q4
$527K Buy
78,600
+25,900
+49% +$178K ﹤0.01% 3342
2024
Q3
$308K Sell
52,700
-28,200
-35% -$196K ﹤0.01% 3588
2024
Q2
$583K Buy
80,900
+52,300
+183% +$457K ﹤0.01% 2697
2024
Q1
$269K Sell
28,600
-8,600
-23% -$49K ﹤0.01% 3485
2023
Q4
$136K Sell
37,200
-3,900
-9% -$11.7K ﹤0.01% 4018
2023
Q3
$129K Sell
41,100
-100
-0.2% -$411 ﹤0.01% 3920
2023
Q2
$143K Sell
41,200
-1,500
-4% -$5.17K ﹤0.01% 3652
2023
Q1
$131K Sell
42,700
-48,500
-53% -$161K ﹤0.01% 3590
2022
Q4
$201K Sell
91,200
-19,800
-18% -$55K ﹤0.01% 3144
2022
Q3
$382K Buy
+111,000
New +$1.07M ﹤0.01% 2910
2022
Q1
Sell
-5,347
Closed -$115K 6058
2021
Q4
$115K Buy
5,347
+40
+0.8% +$1.28K ﹤0.01% 5040
2021
Q3
$187K Buy
5,307
+1,034
+24% +$44.7K ﹤0.01% 5398
2021
Q2
$231K Buy
+4,273
New +$224K ﹤0.01% 4824

Other funds holding DFTX

Wolverine Trading's DFTX Position: Q3 2025 in Review

Wolverine Trading opened a new position in Definium Therapeutics (DFTX) in Q3 2025: 60,250 shares worth $725K. The stake represents ﹤0.01% of the portfolio and ranks #3260 among its holdings. This is a return to the name: Wolverine Trading previously reported a position in DFTX as recently as Q1 2025.

Wolverine Trading first reported a position in DFTX in Q2 2021 and has held it in 13 quarters since. 195 funds tracked by Wall St. Rank hold DFTX as of Q3 2025.

  • Wolverine Trading held 60,250 shares of Definium Therapeutics worth $725K as of Q3 2025.
  • Definium Therapeutics was a new Wolverine Trading position in Q3 2025.
  • Definium Therapeutics made up ﹤0.01% of Wolverine Trading's portfolio in Q3 2025, its #3260 holding.
  • Wolverine Trading first reported a position in Definium Therapeutics in Q2 2021 and has held it in 13 quarters since.
  • 195 funds tracked by Wall St. Rank held Definium Therapeutics as of Q3 2025.

Based on Wolverine Trading's 13F filing for Q3 2025, filed 14 Nov 2025.